Skip to main content

AstraZeneca bruises Stoxx 600 after it rejects Pfizer

European stock markets move lower on Monday, with AstraZeneca leading the charge south after rejecting a sweetened offer from Pfizer, while mining firms decline on the back of further signs of a slowdown in the Chinese housing market.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.